https://doi.org/10.21955/gatesopenres.1114891.1
Document
NOT PEER REVIEWED
Download
CITE
How to cite this document:
Gold ER, Ali-Khan SE, Allen L et al. An Open Toolkit for Tracking Open Science Partnership Implementation and Impact [version 1; not peer reviewed]. Gates Open Res 2018, 2:54
(document)
(https://doi.org/10.21955/gatesopenres.1114891.1)
NOTE: it is important to ensure the information in square brackets after the title is included in this citation.
info_outline
An updated version of this document is available here.
Policy document
An Open Toolkit for Tracking Open Science Partnership Implementation and Impact
E. Richard Gold1,
Sarah E. Ali-Khan2,
Liz Allen3,
Lluis Ballell4,
Manoel Barral-Netto5,
David Carr6,
Damien Chalaud7,
Simon Chaplin6,
Matthew S. Clancy8,
Patricia Clarke9,
Robert Cook-Deegan10,
Megan Doerr11,
Lisa Federer12,
Steven A. Hill13,
Neil Jacobs14,
Antoine Jean15,
Osmat Azzam Jefferson16,
Chonnettia Jones6,
Linda J. Kahl17,
Thomas M. Kariuki18,
Sophie N. Kassel15,
Robert Kiley6,
Elizabeth Robboy Kittrie12,
Bianca Kramer19,
Wen Hwa Lee20,
Emily MacDonald15,
Lara M. Mangravite11,
Elizabeth Marincola18,
Daniel Mietchen21,
Jennifer C. Molloy22,
Mark Namchuk23,
Brian A. Nosek24,
Sébastien Paquet25,
Claude Pirmez5,
Annabel Seyller7,
Malcolm Skingle26,
S. Nicole Spadotto15,
Sophie Staniszewska27,
Mike Thelwall28
Published 29 Oct 2018
(https://doi.org/10.21955/gatesopenres.1114891.1)
Author Affiliations
1 Centre for Intellectual Property and Policy (CIPP), Faculty of Law, McGill University; Department of Human Genetics, Faculty of Medicine, McGill University, Montreal, QC, Canada
2 Centre for Intellectual Property and Policy (CIPP), Faculty of Law, McGill University; Tanenbaum Open Science Institute (TOSI), Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada
3 F1000, London, UK
4 Diseases of the Developing World, Global Health R&D, GlaxoSmithKline, Madrid, Spain
5 Fundação Oswaldo Cruz - Fiocruz, Rio de Janeiro, RJ, Brazil
6 Wellcome Trust, London, UK
7 Montreal Neurological Institute and Hospital, Montreal, QC, Canada
8 US Department of Agriculture Economic Research Service, Washington, DC, USA
9 Health Research Board, Dublin, Ireland
10 School for the Future of Innovation in Society, Arizona State University, Washington, DC, USA
11 Sage Bionetworks, Seattle, WA, USA
12 US National Library of Medicine, Bethesda, MD, USA
13 Research England, UK Research and Innovation, Bristol, UK
14 Jisc, Bristol, UK
15 Centre for Intellectual Property and Policy (CIPP), Faculty of Law, McGill University, Montreal, QC, Canada
16 Queensland University of Technology; The Lens, Brisbane, QLD, Australia
17 The Lens, Canberra, ACT, Australia
18 African Academy of Sciences, Karen, Nairobi, Kenya
19 Utrecht University Library, Utrecht, UT, The Netherlands
20 Structural Genomics Consortium, University of Oxford, Oxford, UK
21 Data Science Institute, University of Virginia, Charlottesville, VA, USA
22 University of Cambridge, Cambridge, UK
23 Alkermes, Waltham, MA, USA
24 Center for Open Science (COS), University of Virginia, Charlottesville, VA, USA
25 Element AI, Montreal, QC, Canada
26 GlaxoSmithKline, Stevenage, UK
27 Warwick Research in Nursing, University of Warwick Medical School, Coventry, UK
28 University of Wolverhampton, Wolverhampton, UK
2 Centre for Intellectual Property and Policy (CIPP), Faculty of Law, McGill University; Tanenbaum Open Science Institute (TOSI), Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada
3 F1000, London, UK
4 Diseases of the Developing World, Global Health R&D, GlaxoSmithKline, Madrid, Spain
5 Fundação Oswaldo Cruz - Fiocruz, Rio de Janeiro, RJ, Brazil
6 Wellcome Trust, London, UK
7 Montreal Neurological Institute and Hospital, Montreal, QC, Canada
8 US Department of Agriculture Economic Research Service, Washington, DC, USA
9 Health Research Board, Dublin, Ireland
10 School for the Future of Innovation in Society, Arizona State University, Washington, DC, USA
11 Sage Bionetworks, Seattle, WA, USA
12 US National Library of Medicine, Bethesda, MD, USA
13 Research England, UK Research and Innovation, Bristol, UK
14 Jisc, Bristol, UK
15 Centre for Intellectual Property and Policy (CIPP), Faculty of Law, McGill University, Montreal, QC, Canada
16 Queensland University of Technology; The Lens, Brisbane, QLD, Australia
17 The Lens, Canberra, ACT, Australia
18 African Academy of Sciences, Karen, Nairobi, Kenya
19 Utrecht University Library, Utrecht, UT, The Netherlands
20 Structural Genomics Consortium, University of Oxford, Oxford, UK
21 Data Science Institute, University of Virginia, Charlottesville, VA, USA
22 University of Cambridge, Cambridge, UK
23 Alkermes, Waltham, MA, USA
24 Center for Open Science (COS), University of Virginia, Charlottesville, VA, USA
25 Element AI, Montreal, QC, Canada
26 GlaxoSmithKline, Stevenage, UK
27 Warwick Research in Nursing, University of Warwick Medical School, Coventry, UK
28 University of Wolverhampton, Wolverhampton, UK
Copyright © 2018 Gold ER et al. This is an open access work distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Metrics
- 1369 Views
- 127 Downloads
How to cite this document:
Gold ER, Ali-Khan SE, Allen L et al. An Open Toolkit for Tracking Open Science Partnership Implementation and Impact [version 1; not peer reviewed]. Gates Open Res 2018, 2:54
(document)
(https://doi.org/10.21955/gatesopenres.1114891.1)
NOTE: it is important to ensure the information in square brackets after the title is included in this citation.
Copied OK
Part of the collection
Published 29 Oct 2018
Policy document
An Open Toolkit for Tracking Open Science Partnership Implementation and Impact
info_outline
An updated version of this document is available here.
E. Richard Gold1,
Sarah E. Ali-Khan2,
Liz Allen3,
Lluis Ballell4,
Manoel Barral-Netto5,
David Carr6,
Damien Chalaud7,
Simon Chaplin6,
Matthew S. Clancy8,
Patricia Clarke9,
Robert Cook-Deegan10,
Megan Doerr11,
Lisa Federer12,
Steven A. Hill13,
Neil Jacobs14,
Antoine Jean15,
Osmat Azzam Jefferson16,
Chonnettia Jones6,
Linda J. Kahl17,
Thomas M. Kariuki18,
Sophie N. Kassel15,
Robert Kiley6,
Elizabeth Robboy Kittrie12,
Bianca Kramer19,
Wen Hwa Lee20,
Emily MacDonald15,
Lara M. Mangravite11,
Elizabeth Marincola18,
Daniel Mietchen21,
Jennifer C. Molloy22,
Mark Namchuk23,
Brian A. Nosek24,
Sébastien Paquet25,
Claude Pirmez5,
Annabel Seyller7,
Malcolm Skingle26,
S. Nicole Spadotto15,
Sophie Staniszewska27,
Mike Thelwall28
Author Affiliations
1 Centre for Intellectual Property and Policy (CIPP), Faculty of Law, McGill University; Department of Human Genetics, Faculty of Medicine, McGill University, Montreal, QC, Canada
2 Centre for Intellectual Property and Policy (CIPP), Faculty of Law, McGill University; Tanenbaum Open Science Institute (TOSI), Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada
3 F1000, London, UK
4 Diseases of the Developing World, Global Health R&D, GlaxoSmithKline, Madrid, Spain
5 Fundação Oswaldo Cruz - Fiocruz, Rio de Janeiro, RJ, Brazil
6 Wellcome Trust, London, UK
7 Montreal Neurological Institute and Hospital, Montreal, QC, Canada
8 US Department of Agriculture Economic Research Service, Washington, DC, USA
9 Health Research Board, Dublin, Ireland
10 School for the Future of Innovation in Society, Arizona State University, Washington, DC, USA
11 Sage Bionetworks, Seattle, WA, USA
12 US National Library of Medicine, Bethesda, MD, USA
13 Research England, UK Research and Innovation, Bristol, UK
14 Jisc, Bristol, UK
15 Centre for Intellectual Property and Policy (CIPP), Faculty of Law, McGill University, Montreal, QC, Canada
16 Queensland University of Technology; The Lens, Brisbane, QLD, Australia
17 The Lens, Canberra, ACT, Australia
18 African Academy of Sciences, Karen, Nairobi, Kenya
19 Utrecht University Library, Utrecht, UT, The Netherlands
20 Structural Genomics Consortium, University of Oxford, Oxford, UK
21 Data Science Institute, University of Virginia, Charlottesville, VA, USA
22 University of Cambridge, Cambridge, UK
23 Alkermes, Waltham, MA, USA
24 Center for Open Science (COS), University of Virginia, Charlottesville, VA, USA
25 Element AI, Montreal, QC, Canada
26 GlaxoSmithKline, Stevenage, UK
27 Warwick Research in Nursing, University of Warwick Medical School, Coventry, UK
28 University of Wolverhampton, Wolverhampton, UK
2 Centre for Intellectual Property and Policy (CIPP), Faculty of Law, McGill University; Tanenbaum Open Science Institute (TOSI), Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada
3 F1000, London, UK
4 Diseases of the Developing World, Global Health R&D, GlaxoSmithKline, Madrid, Spain
5 Fundação Oswaldo Cruz - Fiocruz, Rio de Janeiro, RJ, Brazil
6 Wellcome Trust, London, UK
7 Montreal Neurological Institute and Hospital, Montreal, QC, Canada
8 US Department of Agriculture Economic Research Service, Washington, DC, USA
9 Health Research Board, Dublin, Ireland
10 School for the Future of Innovation in Society, Arizona State University, Washington, DC, USA
11 Sage Bionetworks, Seattle, WA, USA
12 US National Library of Medicine, Bethesda, MD, USA
13 Research England, UK Research and Innovation, Bristol, UK
14 Jisc, Bristol, UK
15 Centre for Intellectual Property and Policy (CIPP), Faculty of Law, McGill University, Montreal, QC, Canada
16 Queensland University of Technology; The Lens, Brisbane, QLD, Australia
17 The Lens, Canberra, ACT, Australia
18 African Academy of Sciences, Karen, Nairobi, Kenya
19 Utrecht University Library, Utrecht, UT, The Netherlands
20 Structural Genomics Consortium, University of Oxford, Oxford, UK
21 Data Science Institute, University of Virginia, Charlottesville, VA, USA
22 University of Cambridge, Cambridge, UK
23 Alkermes, Waltham, MA, USA
24 Center for Open Science (COS), University of Virginia, Charlottesville, VA, USA
25 Element AI, Montreal, QC, Canada
26 GlaxoSmithKline, Stevenage, UK
27 Warwick Research in Nursing, University of Warwick Medical School, Coventry, UK
28 University of Wolverhampton, Wolverhampton, UK
Abstract
Gates Foundation grant number
OPP1183051
Competing Interests
No competing interests were disclosed
Keywords
Open science, innovation, intellectual property, toolkit, performance, indicator, policy, partnership, implementation, impact
An Open Toolkit for Tracking Open Science Partnership... | Documents | Gates Open Research
All commenters must hold a formal affiliation as per our Policies. The information that you give us will be displayed next to your comment.
User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the User Comment Terms and Conditions. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.
Last Updated: 2 October 2017
Last Updated: 2 October 2017
Gates Open Research is an open access publishing platform controlled by the Bill & Melinda Gates Foundation (“Foundation”). This website, https://GatesOpenResearch.org (“Website”), is hosted and operated by F1000 Research Limited (“Service Provider”) on behalf of the Foundation.
BY CHECKING THE BOX NEXT TO “I ACCEPT THE USER COMMENT TERMS AND CONDITIONS” BEFORE YOU SUBMIT YOUR FIRST USER COMMENT, YOU AGREE TO BE BOUND BY THE GENERAL TERMS AND CONDITIONS AND THESE ADDITIONAL TERMS AND CONDITIONS EVERY TIME YOU SUBMIT A USER COMMENT. PLEASE DO NOT SUBMIT A USER COMMENT ON THIS WEBSITE IF YOU DO NOT AGREE TO THESE TERMS AND CONDITIONS. TERMS NOT DEFINED IN THESE ADDITIONAL TERMS AND CONDITIONS SHALL HAVE THE MEANING PROVIDED IN THE GENERAL TERMS AND CONDITIONS.